Russian firm Pharmasyntez seeks to produce COVID drug remdesivir without patent: Report Ruchika Sharma3 Nov 2020 12:36 PM ISTThe Russian firm has completed a clinical trial of the generic drug, labelled Remdeform, on 300 patients across 23 Russian hospitals, a register entry...
Drug firm FDC launches stronger versions of Favipiravir at Rs 160 per tablet in India Ruchika Sharma31 Oct 2020 1:00 PM ISTThe 800 mg version of the drugs will help reduce the number of tablets to be taken by any patient by 75 percent, it added.
Use of Remdesivir, Favipiravir drugs to treat COVID- 19: SC Asks Centre to clarify stand Ruchika Sharma30 Oct 2020 12:00 PM ISTRemdesivir and Favipiravir are antiviral drugs and their efficacy in treating Covid-19 patients has been a matter of debate among medical experts.
Nations mulling Gilead COVID drug Remdesivir should consider trial failure before showing green flag: WHO scientist Farhat Nasim25 Oct 2020 11:00 AM ISTGeneva: Health officials reviewing Gilead Science Inc's remdesivir against COVID-19 should consider all evidence, including a trial in which the...
Mexico will not follow USFDA in approving Gilead COVID-19 drug: Report Ruchika Sharma25 Oct 2020 10:15 AM ISTMexico City: Mexico will not necessarily follow the U.S. Food and Drug Administration (FDA) in approving Gilead Science Inc's antiviral drug...
Govt excludes anti-parasitic drug Ivermectin from Covid-19 treatment protocol Ruchika Sharma25 Oct 2020 9:30 AM ISTA government official said, "It has been decided not to recommend ivermectin medicine in the National Clinical Management Protocol for Covid19 as...
Gilead Sciences Covid drug Remdesivir Becomes First Treatment to Win USFDA Nod Ruchika Sharma24 Oct 2020 4:48 PM ISTNew Delhi: Gilead Sciences has recently been granted approval by the U.S. Food and Drug Administration(USFDA) for antiviral drug Veklury (remdesivir)...
Gilead contests WHO study claiming Covid drug Remdesivir Failed to Reduce Mortality Ruchika Sharma17 Oct 2020 9:30 AM ISTUS: Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its Covid-19 drug remdesivir does not...
Covid-19: Daewoong Pharma gets regulatory okay for phase 1 trial of anti-parasitic niclosamide drug Ruchika Sharma13 Oct 2020 3:00 PM ISTDaewoong had said its anti-viral drug had completely eliminated the novel coronavirus from animals' lungs during pre-clinical testing.
Battling Covid-19: India hands over 3,000 vials of Remdesivir to Myanmar Ruchika Sharma6 Oct 2020 1:18 PM ISTThe intravenous antiviral drug, Remdesivir, is used to treat COVID-19.
Hetero unveils Favivir 800/200 priced at Rs 2640 per pack Ruchika Sharma26 Sept 2020 12:15 PM IST"The launch of 'Favivir 800/2000' is aimed at enhancing patients' adherence to treatment regimen by reducing the number of pills they are required to...
FIRST: Russia okays R-Pharm Covid-19 prescription drug for sale in pharmacies Ruchika Sharma19 Sept 2020 2:00 PM ISTR-Pharm has started talks with pharmacies about orders, the company's spokeswoman said, with Coronavir supplies expected to be rolled out in the near...
